Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Kumar

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
Open Forum Infectious Diseases|January 31, 2019
Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011-2017)Nang Thu Thu Kyaw, Srinath Satyanarayana, Htun Nyunt Oo, et al.
Plos One|October 3, 2012
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, et al.
Plos One|December 11, 2023
Feasibility, enablers and challenges of using timeliness metrics for household contact tracing and TB preventive therapy in PakistanBushra Jamil, Divya Nair, Pruthu Thekkur, et al.
BMJ Open|January 1, 2020
Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods studyBharatkumar Hargovandas Patel, Kathiresan Jeyashree, Palanivel Chinnakali, et al.
Tropical Medicine and Infectious Disease|June 2, 2021
Operational Research to Assess the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Health Facilities in Harare, ZimbabwePruthu Thekkur, Kudakwashe C Takarinda, Collins Timire, et al.
Global Health, Science and Practice|August 30, 2022
Screening for Severe Illness at Diagnosis Has the Potential to Prevent Early TB Deaths: Programmatic Experience From Karnataka, IndiaHemant Deepak Shewade, Sharath Burugina Nagaraja, Basavarajachar Vanitha, et al.
Plos One|April 16, 2015
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?Paresh Dave, Bhavin Vadera, Ajay M V Kumar, et al.
IJTLD Open|June 26, 2024
Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in KenyaD Nair, P Thekkur, I Mbithi, et al.
Plos One|February 6, 2016
Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, IndiaParesh Vamanrao Dave, Amar Niranjan Shah, Pankaj B Nimavat, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatmentA D Harries, Y Lin, P Thekkur, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
Open Forum Infectious Diseases|January 31, 2019
Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011-2017)Nang Thu Thu Kyaw, Srinath Satyanarayana, Htun Nyunt Oo, et al.
Plos One|October 3, 2012
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, et al.
Plos One|December 11, 2023
Feasibility, enablers and challenges of using timeliness metrics for household contact tracing and TB preventive therapy in PakistanBushra Jamil, Divya Nair, Pruthu Thekkur, et al.
BMJ Open|January 1, 2020
Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods studyBharatkumar Hargovandas Patel, Kathiresan Jeyashree, Palanivel Chinnakali, et al.
Tropical Medicine and Infectious Disease|June 2, 2021
Operational Research to Assess the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Health Facilities in Harare, ZimbabwePruthu Thekkur, Kudakwashe C Takarinda, Collins Timire, et al.
Global Health, Science and Practice|August 30, 2022
Screening for Severe Illness at Diagnosis Has the Potential to Prevent Early TB Deaths: Programmatic Experience From Karnataka, IndiaHemant Deepak Shewade, Sharath Burugina Nagaraja, Basavarajachar Vanitha, et al.
Plos One|April 16, 2015
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?Paresh Dave, Bhavin Vadera, Ajay M V Kumar, et al.
IJTLD Open|June 26, 2024
Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in KenyaD Nair, P Thekkur, I Mbithi, et al.
Plos One|February 6, 2016
Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, IndiaParesh Vamanrao Dave, Amar Niranjan Shah, Pankaj B Nimavat, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatmentA D Harries, Y Lin, P Thekkur, et al.
Pageof 32